Literature DB >> 32871205

Tumor targeted combination therapy mediated by functional macrophages under fluorescence imaging guidance.

Yan Zhang1, Qiangsong Wang1, Teng Ma1, Dunwan Zhu1, Tianjun Liu2, Feng Lv3.   

Abstract

Imaging-guiding and targeted drug delivery to tumors are essential for precision cancer therapy, which is a challenging goal to achieve extraordinary therapeutic efficacy. Functional live cells-based delivery systems are expected to play an important role in imaging-guiding and targeted drug delivery. Herein, we fabricated a delivery system mediated by IR-820 conjugated macrophages for tumor targeted combination therapy under fluorescence imaging guidance. The functional macrophages by nature could cross the barriers and recruit into tumors, and serve as host cells to targeted deliver drugs to tumors. The pH-sensitive doxorubicin nanoparticles were engulfed by the macrophages to enhance the drug loading and decrease the damage on host cells. IR-820 was anchored into macrophages cytoplasm to achieve the dual function of photothermal therapy and fluorescence imaging guidance. With Balb/C mice bearing murine breast tumor (4 T1) as models, the functional macrophages for their innate tumor tropism could targeted transport these therapeutic drugs into tumor site to exert efficient chemo-photothermal combination therapy. Moreover, fluorescence imaging-guided drug delivery was employed as the visible strategy to provide the optimized therapeutic window based on the fluorescence of IR-820. The multi-functional macrophages-mediated delivery system would provide a potential for precise and targeted delivery of combination therapy.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Chemo-photothermal combination therapy; IR-820; Imaging guidance; Macrophages; Tumor targeted delivery

Year:  2020        PMID: 32871205     DOI: 10.1016/j.jconrel.2020.08.052

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  2 in total

Review 1.  Drug Delivery Systems with a "Tumor-Triggered" Targeting or Intracellular Drug Release Property Based on DePEGylation.

Authors:  Zhe Ren; Tao Liao; Cao Li; Ying Kuang
Journal:  Materials (Basel)       Date:  2022-07-31       Impact factor: 3.748

2.  Nanozyme-laden intelligent macrophage EXPRESS amplifying cancer photothermal-starvation therapy by responsive stimulation.

Authors:  Yan Zhang; Kunpeng Wang; Guozheng Xing; Xia Dong; Dunwan Zhu; Wenzhi Yang; Lin Mei; Feng Lv
Journal:  Mater Today Bio       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.